Loading...

ZTS

Zoetis, Inc. Class A · NYSE

Performance

-0.13%

1W

-1.89%

1M

+0.34%

3M

-11.65%

6M

-12.87%

YTD

+1.69%

1Y

Profile

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Investment Analysis Report: ZTS

Overview

ZTS, a pharmaceutical company in the Health Technology sector, has shown consistent growth in its financial performance over the past three years. In this report, we will analyze ZTS's financial health, earnings and revenue growth, profitability, operating margin, operating cash flow, and capital expendit...

See more ...

Technical Analysis of ZTS 2024-05-31

Overview:

In analyzing the technical indicators for ZTS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.

Trend Analysis:

    ...
See more ...

Recent News & Updates